Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

61509 1497862462HCLSReviewTaiwanJune2017.pdf
Energy Boardroom

What next for Pfizer? Perhaps a return to the popular breakup idea

20.05.2014 / Fierce Pharma

So, Pfizer. What's Plan B? That's what investors are asking, now that CEO Ian Read's $117 billion bid for AstraZeneca hit a wall–and the promised trifecta of lower taxes, cost savings and promising drugs along with it.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: